TY  - GEN
AU  - Kim,Jihun
AU  - Fox,Cameron
AU  - Peng,Shouyong
AU  - Pusung,Mark
AU  - Pectasides,Eirini
AU  - Matthee,Eric
AU  - Hong,Yong Sang
AU  - Do,In-Gu
AU  - Jang,Jiryeon
AU  - Thorner,Aaron R
AU  - Van Hummelen,Paul
AU  - Rustgi,Anil K
AU  - Wong,Kwok-Kin
AU  - Zhou,Zhongren
AU  - Tang,Ping
AU  - Kim,Kyoung-Mee
AU  - Lee,Jeeyun
AU  - Bass,Adam J
TI  - Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma
SN  - 1558-8238
PY  - 2015///0708
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Drug Resistance, Neoplasm
KW  - ErbB Receptors
KW  - Esophageal Neoplasms
KW  - diet therapy
KW  - Female
KW  - Gene Amplification
KW  - drug effects
KW  - Humans
KW  - Male
KW  - Phosphatidylinositol 3-Kinases
KW  - Receptor, ErbB-2
KW  - Stomach Neoplasms
KW  - Trastuzumab
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1172/JCI75200
ER  -